Literature DB >> 28961490

Effects of dynamic changes in histone acetylation and deacetylase activity on pulmonary fibrosis.

Mingwei Li1, Yi Zheng2, Huihui Yuan3, Yuan Liu4, Xiaohong Wen5.   

Abstract

OBJECTIVE: Histone deacetylases (HDACs) play an important role in dysregulation of histone acetylation/deacetylation, which is the main driving force of the progression of pulmonary fibrosis. Here we investigated the changes in histone acetylation/deacetylation, and the contribution of specific class I and class II HDACs in the progression of pulmonary fibrosis.
METHODS: Male C57BL/6J mice received a single dose of tracheal administration of bleomycin to establish the pulmonary fibrosis model. The changes in acetylation rate of histone 3 (H3) and histone 4 (H4), and the activity of HDAC2 and HDAC4 in the lung tissue during the progression from alveolitis to pulmonary fibrosis were measured.
RESULTS: The acetylation rate of H3/H4 significantly decreased during alveolitis and the early and middle stages of fibrosis, but restored in the late stage of fibrosis. Correlation analysis showed that H4 deacetylation affected both alveolitis and pulmonary fibrosis. H3 deacetylation only affected alveolitis. HDAC2 activity significantly increased in the middle and late stages of pulmonary fibrosis. There was no significant difference in HDAC4 activity between bleomycin and saline groups. However, HDAC4 activity changed significantly with the progression of the disease in bleomycin group. The changes in HDAC2 and HDAC4 activity were different. HDAC2 had long-lasting effects, while HDAC4 had transient effects. Correlation analysis showed that HDAC2 and HDAC4 activity was positively correlated with alveolitis score and fibrosis score.
CONCLUSIONS: The changes in histone acetylation may directly regulate the gene expression of inflammatory cytokines/fibronectin and thus affect the progression of pulmonary fibrosis. The injury-induced histone deacetylation switched into acetylation at the late stage of pulmonary fibrosis, which may be involved in the repair process. HDAC2 is mainly involved in the chronic progression of pulmonary fibrosis, and HDAC4 is mainly involved in early stress response to pulmonary fibrosis.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Epigenetics; Histone acetylation; Histone deacetylase; Pulmonary fibrosis

Mesh:

Substances:

Year:  2017        PMID: 28961490     DOI: 10.1016/j.intimp.2017.09.020

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  11 in total

Review 1.  Metabolic requirements of pulmonary fibrosis: role of fibroblast metabolism.

Authors:  Robert B Hamanaka; Gökhan M Mutlu
Journal:  FEBS J       Date:  2021-01-03       Impact factor: 5.542

Review 2.  Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option.

Authors:  Martina Korfei; Poornima Mahavadi; Andreas Guenther
Journal:  Cells       Date:  2022-05-12       Impact factor: 7.666

Review 3.  The role of metabolic reprogramming and de novo amino acid synthesis in collagen protein production by myofibroblasts: implications for organ fibrosis and cancer.

Authors:  Robert B Hamanaka; Gökhan M Mutlu
Journal:  Amino Acids       Date:  2021-05-08       Impact factor: 3.520

4.  Macrophage activation in the lung during the progression of nitrogen mustard induced injury is associated with histone modifications and altered miRNA expression.

Authors:  Alessandro Venosa; L Cody Smith; Andrew J Gow; Helmut Zarbl; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2021-05-07       Impact factor: 4.460

Review 5.  The oncogenic landscape of the idiopathic pulmonary fibrosis: a narrative review.

Authors:  Giulia Maria Stella; Vito D'Agnano; Davide Piloni; Laura Saracino; Sara Lettieri; Francesca Mariani; Andrea Lancia; Chandra Bortolotto; Pietro Rinaldi; Francesco Falanga; Cristiano Primiceri; Angelo Guido Corsico; Andrea Bianco
Journal:  Transl Lung Cancer Res       Date:  2022-03

Review 6.  HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis.

Authors:  Xing Lyu; Min Hu; Jieting Peng; Xiangyu Zhang; Yan Y Sanders
Journal:  Ther Adv Chronic Dis       Date:  2019-07-18       Impact factor: 4.970

7.  Integrative Proteome and Acetylome Analyses of Murine Responses to Cryptococcus neoformans Infection.

Authors:  Hailong Li; Yanjian Li; Tianshu Sun; Wei Du; Zhijie Zhang; Dancheng Li; Chen Ding
Journal:  Front Microbiol       Date:  2020-04-17       Impact factor: 5.640

8.  MicroRNA-489 suppresses isoproterenol-induced cardiac fibrosis by downregulating histone deacetylase 2.

Authors:  Xiaoyu Yang; Tianhong Yu; Sheng Zhang
Journal:  Exp Ther Med       Date:  2020-01-23       Impact factor: 2.447

9.  Dual inhibition of HDAC and tyrosine kinase signaling pathways with CUDC-907 attenuates TGFβ1 induced lung and tumor fibrosis.

Authors:  Wentian Zhang; Yajie Zhang; Tian Tu; Sabastian Schmull; Yu Han; Wenbo Wang; Hecheng Li
Journal:  Cell Death Dis       Date:  2020-09-17       Impact factor: 8.469

Review 10.  Molecular Mechanisms and Epigenetic Regulation in Diabetic Cardiomyopathy.

Authors:  Anupam Mittal; Rajni Garg; Ajay Bahl; Madhu Khullar
Journal:  Front Cardiovasc Med       Date:  2021-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.